Genetic Basis of Congenital Heart Defects: Genes, Environment, and Counseling

Epidemiology

CHDs affect ~1% of live births (40,000/year in US). Most are multifactorial: genetic susceptibility + environmental triggers.

Key Genetic Pathways

Environmental Risk Factors

  • Maternal diabetes (pregestational > gestational) → 3–5× risk
  • Rubella, CMV, toxoplasmosis (1st trimester)
  • Alcohol (no safe threshold), teratogenic drugs (isotretinoin, valproate, thalidomide)
  • Folate deficiency (periconceptional supplementation reduces risk)
  • Obesity, advanced maternal age, assisted reproductive technology

Genetic Counseling

  • Recurrence risk: 2–5% for isolated CHD (vs. 1% general); higher if syndromic
  • Testing: chromosomal microarray, targeted panels, exome sequencing
  • Prenatal: fetal echo at 18–22 weeks if risk factors

Treatment Outlook

Advances in surgical/interventional techniques allow >90% survival to adulthood for most defects. Lifelong cardiology follow-up needed.

Genetic Disorders - Related Articles

Health Sciences © https://www.222health.com

ProcessExample GenesAssociated Defects
Cardiogenesis (heart tube formation, looping)NKX2-5, TBX5, GATA4, HAND1/2ASD, VSD, conduction defects
Neural crest migration (outflow tract)TFAP2B, SEMA3C, PLXNA2TOF, TGA, PTA, IAA
Left-right patterningNODAL, LEFTY2, ZIC3Heterotaxy, AVSD
Chromatin remodelingCHD7, KMT2D, KDM6ACHARGE, Kabuki syndromes